Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 25, 2019
Oakrum Pharma has entered into an agreement with Aucta to develop and manufacture four prescription generic pharmaceutical products that are intended to be commercialized in the U.S. under the Oakrum label.
read more
Monday, February 25, 2019
Codexis announces the appointment of Laurie Heilmann to Senior Vice President of Business Development and Marketing.
read more
Monday, February 25, 2019
Emergex Vaccines has successfully secured a state-of-the-art-research and development (R&D) facility at Milton Park, Oxfordshire.
read more
Monday, February 25, 2019
WuXi Biologics announced that the EMA has completed the PAI of the company's cGMP Drug Substance and Drug Product manufacturing facilities for the production of Trogarzo with no critical findings.
read more
Monday, February 25, 2019
Roche and Spark Therapeutics announced that they have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction.
read more
Friday, February 22, 2019
Catalent Pharma Solutions announced the appointment of Kay Schmidt as Senior Vice President, Technical Operations.
read more
Friday, February 22, 2019
AveXis will create 200 jobs as it expands its manufacturing center in Durham County, North Carolina, Governor Roy Cooper has announced.
read more
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
Thursday, February 21, 2019
Bioanalytical Systems announced Joe Flynn has been appointed as Chief Commercial Officer of the Company, effective as of February 21, 2019.
read more
Thursday, February 21, 2019
IQVIA has announced the appointment of Carol J. Burt to its board of directors, effective immediately.
read more
Thursday, February 21, 2019
Dr. Reddy’s announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone sublingual film, in the U.S. market.
read more
Thursday, February 21, 2019
MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology, has been acquired by ICON.
read more
Wednesday, February 20, 2019
QPharma has been engaged by several new clients in 2019, including a Top 15 pharmaceutical manufacturer, to provide a global KOL engagement and HCP targeting solution.
read more
Wednesday, February 20, 2019
Teva Pharmaceutical announced a settlement with the Federal Trade Commission (FTC) that will resolve all outstanding litigation between the parties.
read more
Wednesday, February 20, 2019
PPD and HLT of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market delivering data science-driven clinical trials.
read more